e-learning
resources
Paris 2018
Monday, 17.09.2018
Preventing asthma and COPD exacerbations by increasing the inhaled glucocorticoid dose
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Quintupling inhaled glucocorticoids to prevent childhood asthma exacerbations
D. Jackson (Madison, United States of America)
Source:
International Congress 2018 – Preventing asthma and COPD exacerbations by increasing the inhaled glucocorticoid dose
Session:
Preventing asthma and COPD exacerbations by increasing the inhaled glucocorticoid dose
Session type:
Hot topics
Number:
2105
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Jackson (Madison, United States of America). Quintupling inhaled glucocorticoids to prevent childhood asthma exacerbations. International Congress 2018 – Preventing asthma and COPD exacerbations by increasing the inhaled glucocorticoid dose
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
An economic evaluation of adding inhaled corticosteroids to systemic corticosteroids for treating acute asthma exacerbations
Source: International Congress 2019 – Severe acute asthma and troublesome wheezing
Year: 2019
Inhaled budesonide for the treatment of chronic wheezing in early childhood
Source: Eur Respir J 2003; 22: Suppl. 45, 132s
Year: 2003
Could montelukast reduce asthma exacerbations?
Source: Annual Congress 2008 - Advances in the treatment and pathogenesis of pulmonary diseases
Year: 2008
Inhaled corticosteroids in the treatment of acute asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 305s
Year: 2002
The role of inhaled corticosteroids in the management of acute asthma
Source: Eur Respir J 2007; 30: 1035-1037
Year: 2007
Severe exacerbations, decline in lung function and inhaled budesonide in asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 619s
Year: 2007
Quadrupling the inhaled glucocorticoid dose to abort asthma exacerbations
Source: International Congress 2018 – Preventing asthma and COPD exacerbations by increasing the inhaled glucocorticoid dose
Year: 2018
Childhood asthma and responses to inhaled bronchodilating agents during early wheezing
Source: Eur Respir J 2005; 26: Suppl. 49, 625s
Year: 2005
Utility of aerosolized budesonide therapy in acute moderate exacerbations of asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 283s
Year: 2003
Inhaled steroids in exacerbations of COPD
Source: Eur Respir J 2007; 30: 398
Year: 2007
Estimate of asthma control and adherence to inhaled corticosteroids in children with asthma
Source: Annual Congress 2010 - Managing asthma and allergic disease in children
Year: 2010
Effects of inhaled corticosteroids on cough in asthma patients
Source: Eur Respir J 2004; 24: Suppl. 48, 347s
Year: 2004
Long-term adherence to inhaled corticosteroids and asthma control in adult-onset asthma
Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Year: 2020
Oral corticosteroids in the treatment of exacerbation of severe asthma
Source: Virtual Congress 2020 – Exhaled biomarkers of asthma and the asthma burden
Year: 2020
To assess the effects of combined nasal and inhaled corticosteroid in patients with asthma and persistent allergic rhinitis
Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases
Year: 2009
Persistent airway inflammation in young allergic wheezing children treated with inhaled corticosteroids
Source: Annual Congress 2003 - Current issues on wheezing in infancy
Year: 2003
Inhaled corticosteroids and hospitalisation due to exacerbation of COPD
Source: Eur Respir J 2003; 22: 286-289
Year: 2003
The importance of early applying inhaled corticosteroids in patients with mild bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 57s
Year: 2002
Determinants of adherence to inhaled corticosteroids in children with asthma
Source: Annual Congress 2010 - Managing asthma and allergic disease in children
Year: 2010
Utility of high dose inhaled fluticasone therapy for the early management of acute exacerbations of asthma
Source: Annual Congress 2009 - Next generation bronchodilators
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept